Seoul [South Korea], December 30 (ANI/Global Economic): Seegene, a Korean molecular diagnostic company, announced on the 29th that it will export 1.7 million doses of COVID-19 test reagent to Israel.

As urgent demand for test reagent increased due to COVID-19 Omicron variant, Seegene has decided to ship products by a chartered flight. The flight will depart from Incheon Airport on the 29th, and will arrive in Israel on the 30th.

Also Read | Robin Fransman, Dutch Economist and Outspoken Skeptic of COVID-19 Vaccines Dies From Coronavirus Complications.

Seegene said that the diagnostic reagent exported to Israel can detect Omicron variants as well as existing COVID-19 viruses.

This product can detect four existing COVID-19 virus genes and five variant genes. It diagnoses Omicron variant by detecting three variant genes included in Omicron virus. (ANI/Global Economic)

Also Read | Omicron Cases Likely to Peak by End of January, 2022, Says Anthony Fauci.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)